Arena Pharmaceuticals (ARNA) Pops Past $7

12:30pm (EST)

The $125 billion Spain Bank Aid has turned into a temporary bank aid that Wall Street isn’t buying as the market is trading lower heading into the second half of trading. Futures were showing a strong open when we hit the rack last night but were cut in half before the opening bell.

We mentioned last night and again this morning this news/ euphoria would be short-lived as investors have already turned their focus towards Sunday’s Greek elections.

The rally got off to a good start but lost momentum about 30 minutes after the open as the major averages turned negative.

Arena Pharmaceuticals (ARNA, $7.19, up $0.57) is doing well despite the overall market pullback and has broken through strong resistance at $7. Shares have traded to a high of $7.23 which is a new 52-week high. We have been saying shares have a shot at double-digits by the end of June and we have 2 current option trades showing triple-digit profits.

The call option trade for our Daily is rapidly approaching a 300% gain while the covered call trade for our Weekly Wrap should get our conservative traders a 117% return by mid-July if shares hold current levels.

As we head to press, the Dow is showing a decline of 37 points to 12,517 while the S&P 500 is off by 4 points to 1,321. The Nasdaq is down 10 points to 2,848 and is below the 2,850 level.

We have another New Trade we are recommending today as we continue to build small positions near resistance levels. Subscribers, use limit orders to get the best fills and we will be back in the morning with our next update.

Comments are closed.

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

Blog

Arena Pharmaceuticals (ARNA) Pops Past $7

CFTC Disclosure: